Adjuvant Therapy for High-Risk Stage II or III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study

Purpose: To determine the optimal adjuvant chemotherapy regimen for patients with high-risk stage II or III colon adenocarcinoma, we conducted this propensity score-matched, nationwide, population-based cohort study to estimate the effects of adjuvant treatments in high-risk stage II or III colon ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chia-Lun, Yuan, Kevin Sheng-Po, Wu, Alexander T.H., Wu, Szu-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966630/
https://www.ncbi.nlm.nih.gov/pubmed/31842371
http://dx.doi.org/10.3390/cancers11122003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966630/
https://www.ncbi.nlm.nih.gov/pubmed/31842371
http://dx.doi.org/10.3390/cancers11122003

Ejemplares similares